These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 2482284)

  • 1. Synergistic effects of low-dose hepatocarcinogens in induction of glutathione S-transferase P-positive foci in the rat liver.
    Hasegawa R; Mutai M; Imaida K; Tsuda H; Yamaguchi S; Ito N
    Jpn J Cancer Res; 1989 Oct; 80(10):945-51. PubMed ID: 2482284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of timing of partial hepatectomy on the induction of preneoplastic liver foci in rats given hepatocarcinogens.
    Hasegawa R; Tsuda H; Shirai T; Kurata Y; Masuda A; Ito N
    Cancer Lett; 1986 Jul; 32(1):15-23. PubMed ID: 2427192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulatory interaction between initial clofibrate treatment and subsequent administration of 2-acetylaminofluorene or sodium phenobarbital on glutathione S-transferase positive lesion development.
    Mutai M; Tatematsu M; Aoki T; Wada S; Ito N
    Cancer Lett; 1990 Feb; 49(2):127-32. PubMed ID: 2306705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative effects of carcinogens on the induction of placental glutathione S-transferase-positive liver nodules in a short-term assay and of hepatocellular carcinomas in a long-term assay.
    Ogiso T; Tatematsu M; Tamano S; Tsuda H; Ito N
    Toxicol Pathol; 1985; 13(4):257-65. PubMed ID: 3834582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-dependent effects of 2-acetylaminofluorene on hepatic foci development and cell proliferation in rats.
    Tiwawech D; Hasegawa R; Kurata Y; Tatematsu M; Shibata MA; Thamavit W; Ito N
    Carcinogenesis; 1991 Jun; 12(6):985-90. PubMed ID: 2044205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age-dependent induction of preneoplastic liver cell foci by 2-acetylaminofluorene, phenobarbital and acetaminophen in F344 rats initially treated with diethylnitrosamine.
    Hasegawa R; Takahashi S; Imaida K; Yamaguchi S; Shirai T; Ito N
    Jpn J Cancer Res; 1991 Mar; 82(3):293-7. PubMed ID: 1902451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose and sex dependent effects of 2-acetylaminofluorene, 3'-methyl-4-dimethylaminoazobenzene and DL-ethionine in induction of gamma-glutamyl transpeptidase-positive liver cell foci in rats.
    Tamano S; Tsuda H; Fukushima S; Masui T; Hosoda K; Ito N
    Cancer Lett; 1983 Oct; 20(3):313-21. PubMed ID: 6138146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic properties for the suppression of development of putative preneoplastic glutathione S-transferase placental form-positive foci in the liver of carcinogen-resistant DRH strain rats.
    Denda A; Kitayama W; Konishi Y; Yan Y; Fukamachi Y; Miura M; Gotoh S; Ikemura K; Abe T; Higashi T; Higashi K
    Cancer Lett; 1999 Jun; 140(1-2):59-67. PubMed ID: 10403542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of neoplastic development in rat liver, kidney, oesophagus and forestomach by 4,4'-diaminodiphenylmethane administration.
    Tsuda H; Ogiso T; Hasegawa R; Imaida K; Masui T; Ito N
    Carcinogenesis; 1987 May; 8(5):719-22. PubMed ID: 3581430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resistance of Copenhagen rats to chemical induction of glutathione S-transferase 7-7-positive liver foci.
    Wood GA; Korkola JE; Lee VM; Sarma DS; Archer MC
    Carcinogenesis; 1997 Sep; 18(9):1745-50. PubMed ID: 9328170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strain differences in susceptibility to 2-acetylaminofluorene and phenobarbital promotion of rat hepatocarcinogenesis in a medium-term assay system: quantitation of glutathione S-transferase P-positive foci development.
    Asamoto M; Tsuda H; Kagawa M; de Camargo JL; Ito N; Nagase S
    Jpn J Cancer Res; 1989 Oct; 80(10):939-44. PubMed ID: 2515178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presence of a threshold for promoting effects of phenobarbital on diethylnitrosamine-induced hepatic foci in the rat.
    Kitano M; Ichihara T; Matsuda T; Wanibuchi H; Tamano S; Hagiwara A; Imaoka S; Funae Y; Shirai T; Fukushima S
    Carcinogenesis; 1998 Aug; 19(8):1475-80. PubMed ID: 9744545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential regulation of cytochrome(s) P450 2B1/2 by phenobarbital in hepatic hyperplastic nodules induced by aflatoxin B1 or diethylnitrosamine plus 2-acetylaminofluorene in male F344 rats.
    Chen ZY; Eaton DL
    Toxicol Appl Pharmacol; 1991 Oct; 111(1):132-44. PubMed ID: 1949030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promoting effects of phenobarbital and 3'-methyl-4-dimethylaminoazobenzene on the appearance of gamma-glutamyltranspeptidase positive foci in rat liver pretreated with varying doses of diethylnitrosamine.
    Shirai T; Hosoda K; Hirose K; Hirose M; Ito N
    Cancer Lett; 1985 Sep; 28(2):127-33. PubMed ID: 2865001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different responses to phenobarbital promotion in the development of gamma-glutamyltranspeptidase-positive foci in the liver of rats initiated with diethylnitrosamine, N-hydroxy-2-acetyl-aminofluorene and aflatoxin B1.
    Shirai T; Imaida K; Ohshima M; Fukushima S; Lee MS; King CM; Ito N
    Jpn J Cancer Res; 1985 Jan; 76(1):16-9. PubMed ID: 2857671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reciprocal relationship between development of glutathione S-transferase positive liver foci and proliferation of surrounding hepatocytes in rats.
    Tatematsu M; Aoki T; Kagawa M; Mera Y; Ito N
    Carcinogenesis; 1988 Feb; 9(2):221-5. PubMed ID: 3338104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative stereological studies of a 'selection' protocol of hepatocarcinogenesis following initiation in neonatal male and female rats.
    Dragan YP; Campbell HA; Xu XH; Pitot HC
    Carcinogenesis; 1997 Jan; 18(1):149-58. PubMed ID: 9054601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of rat hepatic glutathione S-transferase placental form positive foci development by concomitant administration of antioxidants to carcinogen-treated rats.
    Asamoto M; Shichino Y; Tsuda H; Ito N
    Cancer Lett; 1990 Nov; 55(1):25-9. PubMed ID: 2245407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A medium-term rat liver bioassay for rapid in vivo detection of carcinogenic potential of chemicals.
    Ito N; Tamano S; Shirai T
    Cancer Sci; 2003 Jan; 94(1):3-8. PubMed ID: 12708466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enzyme deviation patterns in primary rat hepatomas induced by sequential administration of two chemically different carcinogens.
    Sato K; Hatayama I; Hoshino K; Imai F; Tsuchida S; Sato T; Nishimura K; Tatematsu M; Ito N
    Cancer Res; 1981 Oct; 41(10):4147-53. PubMed ID: 6269736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.